All News

Arcadia Biosciences, Inc. (Davis, California), an agricultural food ingredient company that is known for leveraging advanced, proprietary breeding techniques to improve the quality and nutritional content of wheat and soybeans, announced that they will apply their expertise cannabis.

President Trump’s nominee for Attorney General, William Barr, stated in his confirmation hearing that he would not go after cannabis companies that were compliant with state laws. In a recent letter in response to written questions from various senators, Barr has put that statement in writing.

We took a look at our most read articles from 2018; here are the top 8. 

The next step in the lawsuit against the Drug Enforcement Administration (DEA) and Department of Justice (DOJ) was heard this week at the United States Court of Appeals for the Second Circuit.

The New Zealand government passed a law on December 11, 2018, that will establish a regulated medical cannabis scheme within one year.

Jeff Zorn, the CEO and Owner of Cannabis Training University, discusses the different courses they offer, what sets them apart from other cannabis training facilities, and more.

Analytical Testing Lab Supplier Profiles from Pixis Labs and SPEX CertiPrep.

Cannabis Science and Technology is pleased to announce the launch of its editorial advisory board. 

The University of Connecticut (UConn, Storrs, Connecticut) announced plans to offer a class on cannabis horticulture through the Department of Plant Science and Landscape Architecture.

According to a recent New York Times article, doctors in the United Kingdom will be allowed to write prescriptions for medical cannabis as of November 1, 2018.

Front Range Biosciences (FRB), a leading agricultural biotech company specializing in tissue culture propagation of high value crops, announced in a press release on October 4, 2018 (1), that it has completed a $10 million Series A round of financing for cannabis research.

According to a report from CNBC.com (1), the U.S. Drug Enforcement Administration (DEA) has rescheduled GW Pharmaceuticals’ cannabidiol (CBD)-based drug, Epidiolex, to schedule V.

Highlights from the 2018 Cannabis Science Conference

Two U.S. Senators introduced legislation that would allow doctors at the VA to prescribe medical cannabis to veterans in the 31 states that have established medical-marijuana programs.

The Cannabis Science Conference, which took place August 28–29, 2018 in Portland, Oregon, saw another year of record-breaking attendance and exhibitors.

Cannabis Science and Technology magazine is seeking contributed manuscripts for the November 2018 and January 2019 issues.

The FDA released a statement this week about reports of severe illnesses and deaths resulting from the use of synthetic cannabinoid products that have been contaminated with brodifacoum.

The U.S. Food and Drug Administration (FDA) recently approved the drug Epidiolex, which contains cannabidiol (CBD), as an oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy-Lennox-Gastaut syndrome and Dravet syndrome-in patients two years of age and older (1).